Rerx Therapeutics, Inc.
Berkeley, CA
- UEI
- HB9YTKMYVNV7
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 2997 Dwight Way, Berkeley, CA 94704, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Evaluation of novel small molecule targeting lipid and energy homeostasis for treating obesity - abstract: the goal of… | National Institute of Diabetes and Digestive and Kidney Diseases | $2,811,511 |
Quick answers
What is Rerx Therapeutics, Inc.'s UEI?
Rerx Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is HB9YTKMYVNV7.
Where is Rerx Therapeutics, Inc. located?
Rerx Therapeutics, Inc.'s physical address in SAM.gov is 2997 Dwight Way, Berkeley, CA 94704, USA.
Is Rerx Therapeutics, Inc. registered in SAM.gov?
Yes. Rerx Therapeutics, Inc.'s SAM.gov registration is active through January 23, 2027.
What is Rerx Therapeutics, Inc.'s most recent federal award?
Rerx Therapeutics, Inc.'s most recent federal grant award is Evaluation of novel small molecule targeting lipid and energy homeostasis for treating obesity - abstract: the goal of… (R44DK142483), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 10, 2025.
On GovTribe
See Rerx Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors